Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
RESMED INC CDI RECEI Receipt

RSMDF

$24.89Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$37.57B
MVM
+$37.57B
TD Variance
0.117

Every news event mapped to its market reaction — 73 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-01-25+17.7%earningsSeeking AlphaResMed Inc. (RMD) Q2 2024 Earnings Call Transcript
2024-01-25+17.7%earningsSeeking AlphaResMed Inc. 2024 Q2 - Results - Earnings Call Presentation
2024-01-24+13.3%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2023-11-09-8.6%legalSEC EDGARRSMDF 8-K: 5.02 and (SEC Filing)
2026-03-16+7.5%analystSeeking AlphaResMed: Waiting For The Next Catalyst, Initiating With Hold Rating
2023-01-26+6.8%legalSEC EDGARRSMDF 8-K: 2.02, 5.02, 8.01 (SEC Filing)
2025-10-31-5.1%earningsSeeking AlphaResMed Inc. 2026 Q1 - Results - Earnings Call Presentation
2025-10-31-5.1%expansionSeeking AlphaResMed outlines high single-digit growth targets for mask segment as new fabric mask launches drive innovation
2025-10-31-5.1%earningsSeeking AlphaResMed Inc. (RMD) Q1 2026 Earnings Call Transcript
2024-08-02+4.7%earningsSeeking AlphaResMed Inc. (RMD) Q4 2024 Earnings Call Transcript
2026-01-13+4.1%newsSeeking Alpha44th Annual J.P. Morgan Healthcare Conference
2025-04-23-3.7%earningsSeeking AlphaResMed outlines Q4 2025 gross margin target of ~59.9% amid strong product launches
2025-04-23-3.7%earningsSeeking AlphaResMed Inc. (RMD) Q3 2025 Earnings Call Transcript
2025-04-23-3.7%earningsSeeking AlphaResMed Inc. 2025 Q3 - Results - Earnings Call Presentation
2025-04-23-3.7%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2026-01-12+3.4%newsSeeking AlphaResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2024-08-01+3.3%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2023-04-27-2.9%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2025-07-31+2.3%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2022-08-12-2.1%legalSEC EDGARRSMDF 8-K: 7.01, 8.01 (SEC Filing)
2023-03-30-2.0%legalSEC EDGARRSMDF 8-K: 5.02 and (SEC Filing)
2022-01-27-2.0%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2022-10-27-1.8%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2025-01-24+1.7%analystSeeking AlphaResMed: Fully Valued With Medium-Term Challenges (Rating Downgrade)
2022-08-11-1.7%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2022-05-11+1.7%legalSEC EDGARRSMDF 8-K: 5.02 and (SEC Filing)
2023-10-26+1.6%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2021-08-27-1.3%legalSEC EDGARRSMDF 8-K: 5.02 (SEC Filing)
2024-04-26-1.3%earningsSeeking AlphaResMed Inc. 2024 Q3 - Results - Earnings Call Presentation
2024-04-26-1.3%earningsSeeking AlphaResMed Inc. (RMD) Q3 2024 Earnings Call Transcript
2022-04-28+1.3%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2022-07-01-1.2%legalSEC EDGARRSMDF 8-K: 5.02 and (SEC Filing)
2025-01-31+1.2%newsSeeking AlphaResMed targets 59-60% gross margins and expanded global reach for AirSense 11
2025-01-31+1.2%earningsSeeking AlphaResMed Inc. (RMD) Q2 2025 Earnings Call Transcript
2024-08-16-1.2%legalSEC EDGARRSMDF 8-K: 5.02 and (SEC Filing)
2021-10-28-1.2%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2022-06-14-1.1%legalSEC EDGARRSMDF 8-K: 1.01, 7.01 (SEC Filing)
2026-04-15-1.0%analystMT NewswiresBaird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating
2024-07-03-1.0%analystSeeking AlphaResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
2026-04-17-1.0%newsStockStory1 of Wall Street’s Favorite Stock Worth Investigating and 2 Facing Headwinds
2026-04-17-1.0%newsZacksShould You Continue to Hold Resmed Stock in Your Portfolio?
2025-09-23+0.9%newsSeeking AlphaResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript
2026-04-20+0.9%earningsZacksWhy ResMed (RMD) is Poised to Beat Earnings Estimates Again
2026-04-20+0.9%earningsZacksHow to Find Strong Medical Stocks Slated for Positive Earnings Surprises
2021-08-05-0.8%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2025-02-10-0.8%earningsSeeking AlphaRevisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions
2023-08-03+0.7%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2025-11-20-0.7%legalSEC EDGARRSMDF 8-K: 5.02, 5.07 (SEC Filing)
2021-10-07-0.7%legalSEC EDGARRSMDF 8-K: 5.02 (SEC Filing)
2025-06-09-0.7%newsSeeking AlphaResMed: A Sleeping Giant Hiding In Plain Sight
2025-08-18+0.6%legalSEC EDGARRSMDF 8-K: 5.02 and (SEC Filing)
2024-04-25-0.6%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2026-02-01-0.5%newsSeeking AlphaResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
2026-01-31-0.5%earningsSeeking AlphaResMed Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-01-29+0.5%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2024-01-09-0.4%newsSeeking AlphaA First Look At ResMed
2025-10-30-0.4%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2026-04-23-0.4%earningsZacksResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
2026-04-23-0.4%earningsZacksResmed's Q3 Earnings on Deck: What's in Store for the Stock?
2026-04-23-0.4%newsGlobeNewswireLong-Term Care and Home Healthcare Global Market Analysis and Technology Research Report 2026-2030, Profiles of Leading Players - Baxter, Medtronic, Koninklijke Philips, ResMed, Sunrise Medical
2024-10-25-0.3%earningsSeeking AlphaResMed Inc. (RMD) Q1 2025 Earnings Call Transcript
2022-06-30-0.2%legalSEC EDGARRSMDF 8-K: 1.01, 2.03 (SEC Filing)
2026-04-19+0.2%analystInsider MonkeyJPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT
2026-01-30-0.2%newsSeeking AlphaResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments
2026-01-30-0.2%earningsSeeking AlphaResMed Inc. (RMD) Q2 2026 Earnings Call Transcript
2024-10-24-0.2%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2025-08-01+0.1%earningsSeeking AlphaResMed Inc. 2025 Q2 - Results - Earnings Call Presentation
2025-08-01+0.1%newsSeeking AlphaResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend
2025-08-01+0.1%earningsSeeking AlphaResMed Inc. (RMD) Q4 2025 Earnings Call Transcript
2025-08-01+0.1%legalSEC EDGARRSMDF 8-K: 5.02 (SEC Filing)
2021-04-29+0.0%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2025-01-30-0.0%legalSEC EDGARRSMDF 8-K: 2.02, 8.01 (SEC Filing)
2026-04-25—newsSimply Wall St.Is It Time To Reassess ResMed (RMD) After Recent Share Price Weakness
tickerdossier.comtickerdossier.substack.com